Delivery Order SPE2DB20D1100-SPE2DB25FE4W9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,516.83 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tlando 112.5 mg capsules (120-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by September 15, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency issued a delivery order valued at $2,217.60 to AmerisourceBergen Drug Corp for TLANDO 112.5 mg capsules (120-count units) on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed price delivery order was issued under a non-set-aside procurement and represents a continuation of the government's ongoing pharmaceutical supply chain management through AmerisourceBergen's established contract vehicles. This delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,233.81 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 120 capsules of the pharmaceutical product TLANDO 112.5 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently procure...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $814 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide 112.5 mg capsules of Tlando, a medication used to treat HIV, for one day's performance in Conshohocken, Pennsylvania. The prime contractor will deliver 120 capsules of the specified product under the contract. The Defense Logistics Agency Troop Support Medical routinely issues delivery orders...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,182.21 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This non-competitive delivery order was issued on August 13, 2025, with completion targeted for August 14, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, utilizing firm fixed price pricing under a delivery order contract type. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This firm fixed-price delivery order, valued at $1,796.23, represents a non-set-aside competitive award with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This award is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) pharmaceutical product on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages, with a contract ceiling value of $1,262.22. This firm fixed price delivery order is expected to be completed by September 12, 2025, and represents a non-set-aside, competitively awarded transaction. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Testosterone 50 mg/5 gram gel in unit dose 5-gram packages, with a contract ceiling value of $1,419.56 and a firm fixed price structure. The delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing indefinite delivery vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,728.00 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be conducted from the contractor's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen Drug Corp's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4W9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Tlando 112.5 mg capsules (120 count) with a contract value of $3,848.49. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering diverse pharmaceutical products and medical supplies. The company's experience fulfilling federal medical supply contracts across multiple therapeutic domains—from specialty medications and vaccines to medical devices—demonstrates its capability to execute competitively awarded procurement requirements. This particular delivery order for Tlando, a testosterone replacement therapy medication, reflects the company's role in supporting military healthcare systems and other government healthcare entities through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/5/25 |